Meeder Asset Management Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Meeder Asset Management Inc

  • $1.42 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
BUY
$83.14 - $145.99 $33,921 - $59,563
408 New
408 $59,000
Q1 2022

May 10, 2022
SELL
$110.08 - $142.92 $100,613 - $130,628
-914 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$99.73 - $148.48 $91,153 - $135,710
914 New
914 $125,000
Q3 2019

Oct 17, 2019
SELL
$37.38 - $49.47 $93,674 - $123,971
-2,506 Closed
0 $0
Q2 2019

Aug 05, 2019
BUY
$39.79 - $67.01 $99,713 - $167,927
2,506 New
2,506 $109,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email